券商股領漲A股,滬指時隔逾1個月重返3000點,牛市要來了?
格隆匯12月17日丨A股券商股領漲,滬指半日收盤站上3000點,漲0.97%報3013點,深證成指漲1.08%報10268點,創業板指漲0.91%報1796點。兩市2635只股上漲,44股漲停;921只股下跌,1股跌停。 板塊表現中,作為“牛市標杆”的券商股中,南京證券、華安證券、國盛金控、西南證券和中原證券5股漲停。除券商板塊外,多元金融股也漲幅居前,綠庭投資漲停。 分析人士指出,近期政策再度向龍頭券商集中釋放利好,包括深改12條、股指期權擴容、科創板重大資產重組新規和打造航母級券商等,而券商曆來是先導板塊,持續大漲更能説明市場信息在逐步恢復。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.